Derek Lowe says it’s falling behind that US:
Phrases like “fair reward for innovation” and “alternative pricing and reimbursement mechanisms” point to one that might. These seem to be carefully worded calls to let the drug companies make a bit more money, in the hopes that they might find it worthwhile to make some more drugs.
Related posts:
- Does socialized medicine kill off drug research?
- No shame for drug handouts
- Drug reps getting cranky
- Should consumer prescription drug ads be reined in?
- "Avoiding drug companies and their advertisements is not the answer"
- Drug trials funded by patients
- Are patients the real "drug pushers?"
KevinMD.com on Facebook
Comments on this entry are closed.